Related Experiment Video
Updated: Jun 4, 2025

Visualization of G3BP Stress Granules Dynamics in Live Primary Cells
Published on: May 21, 2014
G3BP1/2-Targeting PROTAC Disrupts Stress Granules Dependent ATF4 Migracytosis as Cancer Therapy
Ting Dong1,2, Fabao Zhao3, Mengmeng Wang2
1State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, 2A Nanwei Road, Xicheng District, Beijing 100050, China.
Abstract:
Stress granules (SGs) are membraneless cytoplasmic compartments that form in response to stress stimuli. In these compartments, most translation factors stall, except for activating transcription factor 4 (ATF4), which is preferentially translated to ensure cell survival under stressful conditions. Cancer cells encounter various stress conditions in the tumor microenvironment during tumorigenesis; however, how they exploit the pro-survival effects of ATF4 in SGs remains unclear. G3BP1/2 are central nodes of the SG network, regulating SG dynamics. In this study, we designed two small molecules, #129 and PROTAC (Proteolysis Targeting Chimera) degrader 129 (PT-129), which specifically target the NTF2L domain of G3BP1/2, a crucial hub for protein and RNA interactions. These compounds inhibit the formation of stress granules in stressed cells and disassemble pre-existing stress granules. Furthermore, pharmacological inhibition by PT-129 suppressed fibroblast-mediated cancer cell growth in vitro and reduced tumor growth in vivo. Mechanistically, SG facilitates the delivery of ATF4 from fibroblasts to tumor cells via migracytosis, a primary mediator of fibroblast-associated tumor growth. PT-129-mediated disassembly of stress granules disrupts ATF4 delivery, thereby preventing cancer cell proliferation. These compounds, therefore, represent powerful tools for gaining molecular insights into SGs and hold promise for cancer therapeutic interventions by modulating stress granule dynamics.
Insights
New compounds targeting stress granules (SGs) inhibit cancer growth by blocking the transfer of the survival factor ATF4 from fibroblasts to tumor cells. This discovery offers novel therapeutic strategies for cancer treatment.
Area of Science:
- Cell Biology
- Molecular Oncology
- Biochemistry
Background:
- Stress granules (SGs) are dynamic cytoplasmic structures formed under cellular stress.
- Activating transcription factor 4 (ATF4) is preferentially translated within SGs to promote cell survival.
- The role of SGs and ATF4 in cancer progression within the tumor microenvironment is not fully understood.
Purpose of the Study:
- To investigate the role of stress granules in cancer cell proliferation.
- To develop small molecules targeting SG dynamics for cancer therapy.
- To elucidate the mechanism of ATF4 delivery via SGs in fibroblast-mediated tumor growth.
Main Methods:
- Design and synthesis of small molecules (#129 and PT-129) targeting G3BP1/2.
- Inhibition of stress granule formation and disassembly of pre-existing SGs.
- In vitro and in vivo assays to assess the effect of PT-129 on cancer cell growth and tumor progression.
- Investigation of ATF4 delivery mechanisms via migracytosis.
Main Results:
- Compounds #129 and PT-129 effectively inhibit SG formation and disassemble existing SGs.
- Pharmacological inhibition of SGs by PT-129 suppressed fibroblast-mediated cancer cell growth in vitro.
- PT-129 treatment reduced tumor growth in vivo.
- Stress granules facilitate ATF4 delivery from fibroblasts to tumor cells through migracytosis, which is disrupted by PT-129.
Conclusions:
- Stress granules play a critical role in promoting cancer cell proliferation by mediating ATF4 delivery.
- Targeting G3BP1/2 and modulating SG dynamics with compounds like PT-129 presents a promising therapeutic strategy for cancer.
- These findings provide new molecular insights into SG function and their therapeutic potential in oncology.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
DNA Damage can Stall the Cell Cycle
The Intrinsic Apoptotic Pathway
Abnormal Proliferation
Drugs that Stabilize Microtubules
Drugs that Destabilize Microtubules

